180 related articles for article (PubMed ID: 22156927)
1. Implementation of molecular phenotyping approaches in the personalized surgical patient journey.
Mirnezami R; Kinross JM; Vorkas PA; Goldin R; Holmes E; Nicholson J; Darzi A
Ann Surg; 2012 May; 255(5):881-9. PubMed ID: 22156927
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in metabolomics in oncology.
O'Connell TM
Bioanalysis; 2012 Feb; 4(4):431-51. PubMed ID: 22394143
[TBL] [Abstract][Full Text] [Related]
4. Metabonomics: a useful tool for the future surgeon.
Goldsmith P; Fenton H; Morris-Stiff G; Ahmad N; Fisher J; Prasad KR
J Surg Res; 2010 May; 160(1):122-32. PubMed ID: 19592031
[TBL] [Abstract][Full Text] [Related]
5. Application of Fourier-transform ion cyclotron resonance mass spectrometry to metabolic profiling and metabolite identification.
Ohta D; Kanaya S; Suzuki H
Curr Opin Biotechnol; 2010 Feb; 21(1):35-44. PubMed ID: 20171870
[TBL] [Abstract][Full Text] [Related]
6. Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.
Dumas ME; Kinross J; Nicholson JK
Gastroenterology; 2014 Jan; 146(1):46-62. PubMed ID: 24211299
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry in systems biology: an overview.
Feng X; Liu X; Luo Q; Liu BF
Mass Spectrom Rev; 2008; 27(6):635-60. PubMed ID: 18636545
[TBL] [Abstract][Full Text] [Related]
8. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
Corona G; Rizzolio F; Giordano A; Toffoli G
J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661
[TBL] [Abstract][Full Text] [Related]
9. Challenges in applying chemometrics to LC-MS-based global metabolite profile data.
Want E
Bioanalysis; 2009 Jul; 1(4):805-19. PubMed ID: 21083139
[TBL] [Abstract][Full Text] [Related]
10. Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases.
Mishur RJ; Rea SL
Mass Spectrom Rev; 2012; 31(1):70-95. PubMed ID: 21538458
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect.
Weljie AM; Jirik FR
Int J Biochem Cell Biol; 2011 Jul; 43(7):981-9. PubMed ID: 20797448
[TBL] [Abstract][Full Text] [Related]
12. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.
Watson AP; Egland KA
S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics: available results, current research projects in breast cancer, and future applications.
Claudino WM; Quattrone A; Biganzoli L; Pestrin M; Bertini I; Di Leo A
J Clin Oncol; 2007 Jul; 25(19):2840-6. PubMed ID: 17502626
[TBL] [Abstract][Full Text] [Related]
14. Innovation in metabolomics to improve personalized healthcare.
Cacciatore S; Loda M
Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
[TBL] [Abstract][Full Text] [Related]
15. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
16. NMR and MS methods for metabonomics.
Dieterle F; Riefke B; Schlotterbeck G; Ross A; Senn H; Amberg A
Methods Mol Biol; 2011; 691():385-415. PubMed ID: 20972767
[TBL] [Abstract][Full Text] [Related]
17. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
Roukos DH
Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
[TBL] [Abstract][Full Text] [Related]
18. The promise of metabolic phenotyping in gastroenterology and hepatology.
Holmes E; Wijeyesekera A; Taylor-Robinson SD; Nicholson JK
Nat Rev Gastroenterol Hepatol; 2015 Aug; 12(8):458-71. PubMed ID: 26194948
[TBL] [Abstract][Full Text] [Related]
19. Metabolic signatures of malignant progression in prostate epithelial cells.
Teahan O; Bevan CL; Waxman J; Keun HC
Int J Biochem Cell Biol; 2011 Jul; 43(7):1002-9. PubMed ID: 20633696
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer: the potential of metabolic fingerprinting.
Turano P
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):847-9. PubMed ID: 25109498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
